Volume: 5

1. Correlation between Infiltrations of Tumor-associated Macrophages, Mast Cells, and Dendritic Cells with Clinicopathologic Factors in Advanced Gastric Cancer. Page:206—212
2. Expression Pattern of KLF4 in Korean Gastric Cancers. Page:200—205
3. Suppression of Helicobacter pylori-induced Angiogenesis by a Gastric Proton Pump Inhibitor. Page:191—199
4. The Accuracy of Imprint Cytology in the Intraoperative Diagnosis of Lymph Node Metastasis in Gastric Cancer Surgery. Page:186—190
5. Expression of MAGE in Gastric Cancer Tissues. Page:180—185
6. Can 3-year Disease-free Survival be Substituted for 5-year Overall Survival in Curatively Resected Gastric Cancer?. Page:174—179
7. Clinicopathologic Evaluation of Gastric Polyps Remainding in the Stomach after a Gastrectomy. Page:169—173
8. Comparison of Nodal Staging, of UICC TNM and Japanese Classification, and Prognostic Nodal Grouping of UICC N3M0 in Advanced Gastric Cancer. Page:163—168
9. Clinical Correlation between the Serum Pepsinogen I/II Ratio and Gastric Cancer. Page:158—162
10. Assessment of Nutrition Status and Quality of Life after Curative Resection in Patients with Upper Gastric Cancer: Comparison of Total Gastrectomy and Proximal Gastrectomy. Page:152—157
11. Preoperative and Postoperative Anemia in Patients with Gastric Cancer. Page:146—151
12. Preoperative Chemotherapy in Gastric Cancer. Page:139—145
13. Clinical Significance of Subdividing Gastric Cancer according to the Degree of Invasion of the Muscularis Propria. Page:101—105
14. The Distribution Pattern of Lymphocyte Subsets according to the Level of Serum Albumin in Preoperative Patients with Gastric Cancer. Page:106—112
15. The Significance of Lymphatic, Venous, and Neural Invasion as Prognostic Factors in Patients with Gastric Cancer. Page:113—119
16. Critical Pathway for Operable Gastric Cancer. Page:95—100
17. The Distribution Pattern of Lymphocyte Subsets according to the Level of Serum Albumin in Preoperative Patients with Gastric Cancer. Page:106—112
18. The Significance of Lymphatic, Venous, and Neural Invasion as Prognostic Factors in Patients with Gastric Cancer. Page:113—119
19. Hepatoid Adenocarcinoma of the Stomach with Liver Metastasis. Page:127—132
20. Quality Assurance of Gastric Cancer Surgery. Page:79—88
21. Quality Assurance of Gastric Cancer Surgery. Page:79—88
22. Clinicopathologic Characteristics of and Surgical Strategy for Patients with Submucosal Gastric Carcinomas. Page:89—94
23. Clinicopathologic Characteristics of and Surgical Strategy for Patients with Submucosal Gastric Carcinomas. Page:89—94
24. Cyclin G2 Expression in Gastric-cancer Tissues. Page:273—280
25. Impact of Adjuvant Chemoradiation Therapy on the Postoperative 5-year Survival Rates for Stage-II Gastric Cancer. Page:281—287
26. Clinicopathologic Risk Factors of Hepatic Recurrence after Curative Resection for Gastric Cancer. Page:266—272
27. Clinicopathological Characteristics of Superficially Spreading Early Gastric Cancer. Page:288—294
28. Cyclin G2 Expression in Gastric-cancer Tissues. Page:273—280
29. Impact of Adjuvant Chemoradiation Therapy on the Postoperative 5-year Survival Rates for Stage-II Gastric Cancer. Page:281—287
30. Clinicopathological Characteristics of Superficially Spreading Early Gastric Cancer. Page:288—294
31. Transhiatal Esophagectomy in Cardia and Esophageal Cancer. Page:1—9
32. Methylenetetrahydrofolate Reductase C677T Polymorphism in Gastric Cancer. Page:10—15
33. The Early Experience with a Totally Laparoscopic Distal Gastrectomy. Page:16—22
34. Bone Metastasis after a Curative Resection for Gastric Cancer. Page:23—28
35. Prognostic Values of Preoperative Hematologic Parameters in Gastric Cancer. Page:29—33
36. Expression Pattern of KLF6 in Korean Gastric Cancers. Page:34—39
37. Gastrointestinal Stromal Tumor (GIST) of the Stomach: Clinicopathologic Analysis and Outcome. Page:40—46
38. A Case of Eosinophilic Gastritis Mimicking Borrmann Type-4 Advanced Gastric Cancer. Page:47—51
39. A Case of Locally Recurrent Gastric Cancer at Kim's Tie Site of the Jejunum after a Total Gastrectomy. Page:52—56
40. Curative Resection of Inoperable, Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy with Taxotere and Cisplatin. Page:57—64
41. Critical Pathway for Operable Gastric Cancer. Page:95—100
42. Role of Endoscopic Ultrasonography in the Diagnosis of Gastrointestinal Stromal Tumors in the Stomach. Page:120—126
43. Clinical Significance of Subdividing Gastric Cancer according to the Degree of Invasion of the Muscularis Propria. Page:101—105
44. Hepatoid Adenocarcinoma of the Stomach with Liver Metastasis. Page:127—132
45. Role of Endoscopic Ultrasonography in the Diagnosis of Gastrointestinal Stromal Tumors in the Stomach. Page:120—126
46. Clinicopathologic Risk Factors of Hepatic Recurrence after Curative Resection for Gastric Cancer. Page:266—272
47. Mutation of the Chk1 Gene in Gastric Cancers with Microsatellite Instability. Page:260—265
48. Clinical Experience of Small-cell Carcinomas of the Stomach. Page:252—259
49. Benign Stricture of Esophagojejunostomy after Radical Total Gastrectomy. Page:246—251
50. Clinical Significance of the Ghrelin Concentrations in Plasma and Tumor Tissue from Patients with Gastric Cancer. Page:238—245
51. Methylation of P16 and hMLH1 in Gastric Carcinoma. Page:228—237
52. Positive Rate of Tumor Marker according to Sites of Recurrence in Gastric Cancer. Page:222—227
53. Operative Treatment of Patients Over 75 Years Old with Gastric Cancer. Page:217—221